SinoMab
3681.HKSinoMab BioScience Limited Price (3681.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,018,115,585
(2.6372)%Revenue and Profitability
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1,480,000 | 0 | 12,760,000 | 26,657,000 | 4,032,000 | 1,365,000 |
| Net Income | -47,974,000 | -83,610,000 | -278,620,000 | -122,600,000 | -288,194,000 | -284,158,000 | -243,111,000 |
| FCF USD | -41,023,000 | -49,575,000 | -264,775,000 | -217,293,000 | -345,295,000 | -413,289,000 | -237,739,000 |
| OCF USD | -40,200,000 | -46,829,000 | -222,489,000 | -141,338,000 | -147,063,000 | -300,538,000 | -133,847,000 |
Financial Health - DEBT
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | -0.39 | -0.16 | -0.68 | -0.91 | -1.10 | -1.56 |
| D/E | -4.16 | 2.20 | 0.05 | 0.10 | 0.40 | 0.70 | 1.53 |
| CA/CL | 0.69 | 1.77 | 11.39 | 15.89 | 6.06 | 2.39 | 1.56 |
| TA/TL | 0.76 | 1.45 | 8.43 | 7.93 | 2.88 | 2.02 | 1.54 |
| Total Debt | 211,980,000 | 60,267,000 | 53,614,000 | 97,838,000 | 275,459,000 | 357,183,000 | 450,808,000 |
Management Performance
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| ROIC | -18.30% | -43.23% | -23.30% | -15.24% | -35.27% | -32.61% | -30.76% |
| ROE | 94.16% | -305.08% | -24.61% | -12.42% | -42.37% | -55.76% | -82.25% |
| ROA | 0.00% | -94.14% | -21.51% | -10.85% | -27.67% | -28.18% | -28.68% |
| NM % | - | -5,649.32% | - | -960.82% | -1,081.12% | -7,047.57% | -17,810.33% |
| FCF / R% | 0.00% | -3,349.66% | 0.00% | -1,702.92% | -1,295.33% | -10,250.22% | -17,416.78% |
| FCF / NI% | 79.04% | 59.29% | 95.84% | 177.24% | 119.81% | 145.44% | 97.79% |
| Operating Margin (OM) | - | -186.41 | - | -52.88 | -36.12 | -309.31 | 0.00 |
Per Share
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| EPS | -0.05 | -0.08 | -0.33 | -0.12 | -0.29 | -0.29 | -0.24 |
| SPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.00 |
| OCPS | -0.04 | -0.05 | -0.27 | -0.14 | -0.15 | -0.30 | -0.13 |
| FCPS | -0.04 | -0.05 | -0.32 | -0.22 | -0.35 | -0.42 | -0.23 |
| BVPS | -0.05 | 0.03 | 1.35 | 0.98 | 0.68 | 0.51 | 0.29 |
Per Share - CAGR
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| CAGR-EPS | -0.05 | -0.08 | -0.33 | -0.12 | -0.29 | -0.29 | -0.24 |
| CAGR-SPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.00 |
| CAGR-OCPS | -0.04 | -0.05 | -0.27 | -0.14 | -0.15 | -0.30 | -0.13 |
| CAGR-FCPS | -0.04 | -0.05 | -0.32 | -0.22 | -0.35 | -0.42 | -0.23 |
| CAGR-BVPS | -0.05 | 0.03 | 1.35 | 0.98 | 0.68 | 0.51 | 0.29 |